AU1979283A - Nitroglycerine solution - Google Patents

Nitroglycerine solution

Info

Publication number
AU1979283A
AU1979283A AU19792/83A AU1979283A AU1979283A AU 1979283 A AU1979283 A AU 1979283A AU 19792/83 A AU19792/83 A AU 19792/83A AU 1979283 A AU1979283 A AU 1979283A AU 1979283 A AU1979283 A AU 1979283A
Authority
AU
Australia
Prior art keywords
solution
nitroglycerine
nitroglycerine solution
glycerine
nitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19792/83A
Other languages
English (en)
Inventor
Kurt Burghart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
G Pohl Boskamp GmbH and Co Chemisch Pharmazeutische Fabrik
Original Assignee
Pohl Boskamp G Co Chemisch Pharmazeutische Fabrik GmbH
G Pohl Boskamp GmbH and Co Chemisch Pharmazeutische Fabrik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6175236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU1979283(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pohl Boskamp G Co Chemisch Pharmazeutische Fabrik GmbH, G Pohl Boskamp GmbH and Co Chemisch Pharmazeutische Fabrik filed Critical Pohl Boskamp G Co Chemisch Pharmazeutische Fabrik GmbH
Publication of AU1979283A publication Critical patent/AU1979283A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU19792/83A 1982-10-08 1983-09-30 Nitroglycerine solution Abandoned AU1979283A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3237284 1982-10-08
DE19823237284 DE3237284A1 (de) 1982-10-08 1982-10-08 Loesungsvermittlerfreie, waessrige nitroglycerinloesung

Publications (1)

Publication Number Publication Date
AU1979283A true AU1979283A (en) 1984-04-12

Family

ID=6175236

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19792/83A Abandoned AU1979283A (en) 1982-10-08 1983-09-30 Nitroglycerine solution

Country Status (4)

Country Link
EP (1) EP0108248B2 (cg-RX-API-DMAC10.html)
AT (1) ATE39416T1 (cg-RX-API-DMAC10.html)
AU (1) AU1979283A (cg-RX-API-DMAC10.html)
DE (1) DE3237284A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4007705C1 (cg-RX-API-DMAC10.html) * 1990-03-10 1991-09-26 G. Pohl-Boskamp Gmbh & Co. Chemisch-Pharmazeutische Fabrik, 2214 Hohenlockstedt, De
EP2878310B1 (en) 2013-11-29 2017-01-11 G. Pohl-Boskamp GmbH & Co. KG Sprayable aqueous composition comprising glyceryl trinitrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2301664C3 (de) * 1973-01-13 1979-07-12 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Oral verabreichbares, Nitroglycerin enthaltendes Arzneimittel
JPS599539B2 (ja) * 1979-11-13 1984-03-03 日本化薬株式会社 ニトログリセリン水溶液及びその製造法
DE3109783C2 (de) * 1981-03-13 1987-04-02 Schwarz GmbH, 4019 Monheim Verfahren zur Herstellung einer ethanolfreien Nitroglycerinlösung mit einer Konzentration von etwa 1 mg Nitroglycerin/ml

Also Published As

Publication number Publication date
DE3237284C2 (cg-RX-API-DMAC10.html) 1990-05-31
EP0108248B2 (de) 1999-09-15
EP0108248B1 (de) 1988-12-28
DE3237284A1 (de) 1984-04-12
EP0108248A2 (de) 1984-05-16
ATE39416T1 (de) 1989-01-15
EP0108248A3 (en) 1984-09-05

Similar Documents

Publication Publication Date Title
EG18729A (en) Compound of n- amino - 1,2,4-triazinones used as insecticide.
ES2104605T3 (es) Composiciones estables de acido ascorbico.
ZA886727B (en) Azithromycin and derivatives as antiprotozoal agents
BR8008312A (pt) Aplicacao de peroxido de zinco
FI831230A0 (fi) N-glykosylerade karboxylsyraamidderivat, foerfarande foer deras framstaellning samt deras anvaendnifoer att paoverka kroppens eget foersvar
DE3382637D1 (de) Eine lipidloesliche substanz enthaltende waessrige fluessigkeit.
GR79637B (cg-RX-API-DMAC10.html)
KR880008801A (ko) 비경구 투여용 용액제
AU1979283A (en) Nitroglycerine solution
ES482420A1 (es) Un procedimiento para la preparacion de 4-desoxi-4-acilamino-derivados de eritromicilamina.
EP0146239A3 (en) Bioconversion production of ascorbic acid
IE801149L (en) Trihydroxy-piperidines
FR2526418B1 (fr) Composition propulsive contenant de la nitrocellulose, de la nitroglycerine, du benzoate de cuivre et du plomb ou ses derives, notamment pour fusees
ZA872664B (en) Six-membered heterocyclic derivatives of n'-substituted-n,n'-diacylhydrazines
KR830005168A (ko) 5-(디하이드록시페녹시)테트라졸의 제조방법
GR73158B (cg-RX-API-DMAC10.html)
FI884960A0 (fi) Anvaendning av 2-pyrimidinyl-1-piperazin-derivat.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
GB2194531B (en) 7-oxabicyclo(2.2.1)heptane hydroxamic acid derivatives useful as "dual inhibitors"
DE3368199D1 (en) Mixture comprising a central analgesic and vitamin b12, or one of its analogs, as active principles
KR880012226A (ko) 외 용 제
ATE118209T1 (de) Pyridin-3-percarboxylsäure monopersulfat.
UA5548A1 (uk) Спосіб отримання похідних ізоксазолу
FI930292A0 (fi) Foerfarande foer att avlaegsna syra ur nitrosubstituerade aromater med hjaelp av smaelt nitratsalt
AU553275B2 (en) Stable oxytetracyclin solutions